Epidemiology of valvular heart disease in the adult

Nature Reviews Cardiology

Volumn 8, Issue 3, 2011, Pages 162-172

  Iung, Bernard ^a   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; AORTA STENOSIS; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DEVELOPING COUNTRY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOCARDITIS; HUMAN; INTERVENTION STUDY; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC HEART DISEASE; RISK FACTOR; STAPHYLOCOCCUS; VALVULAR HEART DISEASE;

ADULT; AGE FACTORS; AORTIC VALVE; AORTIC VALVE STENOSIS; DISEASE PROGRESSION; FRANCE; HEART VALVE DISEASES; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; WORLD HEALTH;

EID: 79952183726     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.202     Document Type: Review

References (86)

1. Soler-Soler, J. & Galve, E. worldwide perspective of valve disease. Heart 83, 721-725 (2000). (Pubitemid 30345988)
2. Carapetis, J. R., Steer, A. C., Mulholland, E. K. & weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685-694 (2005). (Pubitemid 41505357)
3. Vahanian, A. et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230-268 (2007). (Pubitemid 46276943)
4. Bonow, R. O. et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 52, e1-e142 (2008).
5. Desjardins, V. A., Enriquez-Sarano, M., Tajik, A. J., Bailey, K. R. & Seward, J. B. Intensity of murmurs correlates with severity of valvular regurgitation. Am. J. Med. 100, 149-156 (1996). (Pubitemid 26062508)
6. Baumgartner, H. et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur. J. Echocardiogr. 10, 1-25 (2009).
7. Lancellotti, P. et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur. J. Echocardiogr. 11, 223-244 (2010).
8. Lancellotti, P. et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur. J. Echocardiogr. 11, 307-332 (2010).
9. Nkomo, V. T. et al. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005-1011 (2006). (Pubitemid 44353666)
10. Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231-1243 (2003). (Pubitemid 36834640)
11. Iung, B. et al. Valvular heart disease in the community: a European experience. Curr. Probl. Cardiol. 32, 609-661 (2007). (Pubitemid 350001365)
12. Zoghbi, w. A. et al. for the American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J. Am. Soc. Echocardiogr. 16, 777-802 (2003). (Pubitemid 37391035)
13. Hull, M. C., Morris, C. G., Pepine, C. J. & Mendenhall, N. P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290, 2831-2837 (2003). (Pubitemid 37509491)
14. Droogmans, S., Kerkhove, D., Cosyns, B. & Van Camp, G. Role of echocardiography in toxic heart valvulopathy. Eur. J. Echocardiogr. 10, 467-476 (2009).
15. Kamblock, J. et al. Acute severe mitral regurgitation during first attacks of rheumatic fever: clinical spectrum, mechanisms and prognostic factors. J. Heart Valve Dis. 14, 440-446 (2005). (Pubitemid 47050711)
16. Tibazarwa, K. B., Volmink, J. A. & Mayosi, B. M. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 94, 1534-1540 (2008).
17. Carapetis, J. R., Currie, B. J. & Mathews, J. D. Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol. Infect. 124, 239-244 (2000). (Pubitemid 30224132)
18. Kaplan, E. L. Pathogenesis of acute rheumatic fever and rheumatic heart disease: evasive after half a century of clinical, epidemiological, and laboratory investigation. Heart 91, 3-4 (2005). (Pubitemid 39664977)
19. Rizvi, S. F. et al. Status of rheumatic heart disease in rural Pakistan. Heart 90, 394-399 (2004). (Pubitemid 38406912)
20. Carapetis, J. R. Rheumatic heart disease in Asia. Circulation 118, 2748-2753 (2008).
21. McLaren, M. J. et al. Epidemiology of rheumatic heart disease in black shcoolchildren of Soweto, Johannesburg. BMJ 3, 474-478 (1975).
22. Essop, M. R. & Nkomo, V. T. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation 112, 3584-3591 (2005). (Pubitemid 43739536)
23. Marijon, E. et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470-476 (2007). (Pubitemid 47204876)
24. Bouma, B. J. et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 82, 143-148 (1999). (Pubitemid 29362861)
25. Stewart, B. F. et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29, 630-634 (1997). (Pubitemid 27116107)
26. Lindroos, M., Kupari, M., Heikkila, J. & Tilvis, R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21, 1220-1225 (1993). (Pubitemid 23106200)
27. Iung, B. Management of the elderly patient with aortic stenosis. Heart 94, 519-524 (2008). (Pubitemid 351441416)
28. Probst, V. et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 113, 856-860 (2006).
29. Parolari, A. et al. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur. J. Cardiothorac. Surg. 35, 493-504 (2009).
30. Cosmi, J. E. et al. The risk of the development of aortic stenosis in patients with 'benign' aortic valve thickening. Arch. Intern. Med. 162, 2345-2347 (2002). (Pubitemid 35332517)
31. Chan, K. L., Ghani, M., woodend, K. & Burwash, I. G. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am. J. Cardiol. 88, 690-693 (2001). (Pubitemid 32831110)
32. Palta, S., Pai, A. M., Gill, K. S. & Pai, R. G. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 101, 2497-2502 (2000). (Pubitemid 30366254)
33. Lester, S. J. et al. Rate of change in aortic valve area during a cardiac cycle can predict the rateof hemodynamic progression of aortic stenosis. Circulation 101, 1947-1952 (2000). (Pubitemid 30225276)
34. Rossebo, A. B. et al. for the SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N. Engl. J. Med. 359, 1343-1356 (2008).
35. Chan, K. L., Teo, K., Dumesnil, J. G., Ni, A. & Tam, J. for the ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 121, 306-314 (2010).
36. Cowell, S. J. et al. for the SALTIRE Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352, 2389-2397 (2005). (Pubitemid 40958435)
37. Garg, V. et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270-274 (2005). (Pubitemid 41294491)
38. Tutar, E., Ekici, F., Atalay, S. & Nacar, N. The prevalence of bicuspid aortic valve in newborns by echocardiographic screening. Am. Heart J. 150, 513-515 (2005). (Pubitemid 41317622)
39. Nistri, S., Basso, C., Marzari, C., Mormino, P. & Thiene, G. Frequency of bicuspid aortic valve in young male conscripts by echocardiogram. Am. J. Cardiol. 96, 718-721 (2005). (Pubitemid 41207320)
40. Lloyd-Jones, D. et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, e46-e215 (2010).
41. Tzemos, N. et al. Outcomes in adults with bicuspid aortic valves. JAMA 300, 1317-1325 (2008).
42. Michelena, H. I. et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 117, 2776-2784 (2008). (Pubitemid 351770458)
43. Roberts, w. C. & Ko, J. M. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111, 920-925 (2005). (Pubitemid 40279895)
44. Sievers, H. H. & Schmidtke, C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J. Thorac. Cardiovasc. Surg. 133, 1226-1233 (2007). (Pubitemid 46656388)
45. Davies, R. R. et al. Natural history of ascending aortic aneurysms in the setting of an unreplaced icuspid aortic valve. Ann. Thorac. Surg. 83, 1338-1344 (2007). (Pubitemid 46440756)
46. Dare, A. J., Veinot, J. P., Edwards, w. D., Tazelar, H. D & Schaff, H. V. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum. Pathol. 24, 1330-1338 (1993). (Pubitemid 24033736)
47. Borer, J. S. et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 97, 525-534 (1998). (Pubitemid 28090681)
48. Singh, J. P. et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am. J. Cardiol. 83, 897-902 (1999). (Pubitemid 29143128)
49. Reid, C. L., Anton-Culver, H., Yunis, C. & Gardin, J. M. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am. J. Cardiol. 99, 830-834 (2007). (Pubitemid 46365608)
50. Underwood, M. J., El Khoury, G., Deronck, D., Glineur, D. & Dion, R. The aortic root: structure, function, and surgical reconstruction. Heart 83, 376-380 (2000). (Pubitemid 30316746)
51. le Polain de waroux, J. B. et al. Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography. Circulation 116, I264-I269 (2007).
52. Padial, L. R. et al. Doppler echocardiographic assessment of progression of aorticregurgitation. Am. J. Cardiol. 80, 306-314 (1997). (Pubitemid 27330147)
53. Roberts, w. C., Ko, J. M., Moore, T. R. & Jones, w. H. 3rd Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 114, 422-429 (2006). (Pubitemid 44264824)
54. Chandrashekhar, Y., westaby, S. & Narula, J. Mitral stenosis. Lancet 374, 1271-1283 (2009).
55. Gordon, S. P., Douglas, P. S., Come, P. C. & Manning, w. J. Two-dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: implications for follow-up. J. Am. Coll. Cardiol. 19, 968-973 (1992).
56. Abdel-Hady, E. S. et al. Maternal and perinatal outcome of pregnancies complicated by cardiac disease. Int. J. Gynaecol. Obstet. 90, 21-25 (2005).
57. Pressman, G. S., Agarwal, A., Braitman, L. E. & Muddassir, S. M. Mitral annular calcium causing mitral stenosis. Am. J. Cardiol. 105, 389-391 (2010).
58. Croft, L. B. et al. Age-related prevalence of cardiac valvular abnormalities warranting infectious endocarditis prophylaxis. Am. J. Cardiol. 94, 386-389 (2004). (Pubitemid 38962716)
59. Avierinos, J. F. et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 106, 1355-1361 (2002).
60. Freed, L. A. et al. Prevalence and clinical outcome of mitral-valve prolapse. N. Engl. J. Med. 341, 1-7 (1999). (Pubitemid 29293713)
61. Rabkin, E. et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104, 2525-2532 (2001). (Pubitemid 33104788)
62. Barber, J. E. et al. Mechanical properties of myxomatous mitral valves. J. Thorac. Cardiovasc. Surg. 122, 955-962 (2001).
63. Kyndt, F. et al. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 115, 40-49 (2007). (Pubitemid 46058610)
64. Avierinos, J. F., Detaint, D., Messika-Zeitoun, D., Mohty, D. & Enriquez-Sarano, M. Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community. Am. J. Cardiol. 101, 662-667 (2008). (Pubitemid 351625094)
65. Barasch, E. et al. Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS). Am. Heart J. 151, 39-47 (2006). (Pubitemid 41815328)
66. Bursi, F. et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111, 295-301 (2005). (Pubitemid 40165335)
67. Grigioni, F., Enriquez-Sarano, M., Zehr, K. J., Bailey, K. R. & Tajik, A. J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103, 1759-1764 (2001). (Pubitemid 32291413)
68. Moller, J. E. et al. Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation 112, 3320-3327 (2005). (Pubitemid 43739378)
69. Hoen, B. et al. for the AEPEI Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288, 75-81 (2002). (Pubitemid 34705521)
70. Tleyjeh, I. M. et al. A systematic review of population-based studies of infective endocarditis. Chest 132, 1025-1035 (2007).
71. Murdoch, D. R. et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern. Med. 169, 463-473 (2009).
72. Tornos, P. et al. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart 91, 571-575 (2005). (Pubitemid 40559341)
73. Sy, R. w. & Kritharides, L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1,536 patients in Australia. Eur. Heart J. 31, 1890-1897 (2010).
74. Duval, X. & Leport, C. Prophylaxis of infective endocarditis: current tendencies, continuingcontroversies. Lancet Infect. Dis. 8, 225-232 (2008). (Pubitemid 351384827)
75. Habib, G. et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur. Heart J. 30, 2369-2413 (2009).
76. The Society of Thoracic Surgeons. Adult Cardiac Surgery Database, Executive Summary, 10 years STS report-period ending 12/31/2009 [online], http://www.sts.org/documents/pdf/ndb2010/1stHarvestExecutiveSummary%5B1%5D.pdf (2010).
77. Brown, J. M. et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg. 137, 82-90 (2009).
78. Gammie, J. S. et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann. Thorac. Surg. 87, 1431-1437 (2009).
79. Vahanian, A. & Palacios, I. F. Percutaneous approaches to valvular disease. Circulation 109, 1572-1579 (2004). (Pubitemid 38451711)
80. Iung, B. et al. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur. Heart J. 25, 701-707 (2004). (Pubitemid 38579500)
81. Marijon, E. et al. what are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure? Arch. Cardiovasc. Dis. 101, 611-617 (2008).
82. Rodes-Cabau, J. et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J. Am. Coll. Cardiol. 55, 1080-1090 (2010).
83. Thomas, M. et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122, 62-69 (2010).
84. Himbert, D. et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J. Am. Coll. Cardiol. 54, 303-311 (2009).
85. Vahanian, A. et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 4, 193-199 (2008).
86. Feldman, T. et al. for the EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J. Am. Coll. Cardiol. 54, 686-694 (2009).